|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.07 USD | -3.30% |
|
-2.39% | +17.96% |
| May. 07 | RBC Capital Adjusts Corteva Price Target to $97 From $95, Maintains Outperform Rating | MT |
| May. 07 | UBS Adjusts Price Target on Corteva to $90 From $88, Maintains Neutral Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.88 | 3.09 | 2.93 | 2.91 | 3.88 | |||||
Return on Total Capital | 6.11 | 4.81 | 4.51 | 4.4 | 5.94 | |||||
Return On Equity % | 7.19 | 4.75 | 3.7 | 3.5 | 4.97 | |||||
Return on Common Equity | 7.22 | 4.75 | 3.69 | 3.49 | 4.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 41.1 | 40.25 | 42.5 | 43.64 | 47.29 | |||||
SG&A Margin | 12.08 | 17.24 | 19.13 | 19.75 | 20.2 | |||||
EBITDA Margin % | 24.77 | 19.03 | 18.68 | 18.8 | 21.83 | |||||
EBITA Margin % | 21.44 | 16.04 | 15.61 | 15.6 | 18.62 | |||||
EBIT Margin % | 16.83 | 12.02 | 11.65 | 11.54 | 14.92 | |||||
Income From Continuing Operations Margin % | 11.64 | 6.97 | 5.46 | 5.1 | 6.92 | |||||
Net Income Margin % | 11.24 | 6.57 | 4.27 | 5.36 | 6.29 | |||||
Net Avail. For Common Margin % | 11.57 | 6.9 | 5.39 | 5.03 | 6.86 | |||||
Normalized Net Income Margin | 10.19 | 6.61 | 5.83 | 5.75 | 8.36 | |||||
Levered Free Cash Flow Margin | 21.48 | 3.65 | 7.08 | 16.44 | 16.84 | |||||
Unlevered Free Cash Flow Margin | 21.6 | 3.93 | 7.92 | 17.31 | 17.48 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.41 | 0.4 | 0.4 | 0.42 | |||||
Fixed Assets Turnover | 3.23 | 3.67 | 3.66 | 3.67 | 3.81 | |||||
Receivables Turnover (Average Receivables) | 4.16 | 4.43 | 3.99 | 3.76 | 3.58 | |||||
Inventory Turnover (Average Inventory) | 1.83 | 1.74 | 1.44 | 1.55 | 1.65 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.63 | 1.56 | 1.56 | 1.45 | 1.43 | |||||
Quick Ratio | 0.98 | 0.84 | 0.79 | 0.85 | 0.9 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | 0.08 | 0.17 | 0.21 | 0.28 | |||||
Days Sales Outstanding (Average Receivables) | 87.71 | 82.31 | 91.57 | 97.42 | 101.87 | |||||
Days Outstanding Inventory (Average Inventory) | 199.17 | 209.83 | 252.61 | 236.81 | 220.84 | |||||
Average Days Payable Outstanding | 148.43 | 136.51 | 167.56 | 188.83 | 163.68 | |||||
Cash Conversion Cycle (Average Days) | 138.45 | 155.63 | 176.61 | 145.4 | 159.03 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.15 | 6.88 | 11.77 | 13.23 | 12.28 | |||||
Total Debt / Total Capital | 5.79 | 6.44 | 10.53 | 11.68 | 10.94 | |||||
LT Debt/Equity | 5.61 | 6.32 | 10.47 | 9.55 | 8.12 | |||||
Long-Term Debt / Total Capital | 5.29 | 5.91 | 9.36 | 8.43 | 7.23 | |||||
Total Liabilities / Total Assets | 39.49 | 40.07 | 41.21 | 41.14 | 43.08 | |||||
EBIT / Interest Expense | 87.83 | 26.56 | 8.61 | 8.38 | 14.42 | |||||
EBITDA / Interest Expense | 135.27 | 44.29 | 14.68 | 14.55 | 22.24 | |||||
(EBITDA - Capex) / Interest Expense | 116.17 | 36.63 | 12.12 | 11.99 | 18.96 | |||||
Total Debt / EBITDA | 0.39 | 0.5 | 0.87 | 0.94 | 0.75 | |||||
Net Debt / EBITDA | -0.73 | -0.45 | 0.07 | 0 | -0.39 | |||||
Total Debt / (EBITDA - Capex) | 0.45 | 0.61 | 1.05 | 1.14 | 0.88 | |||||
Net Debt / (EBITDA - Capex) | -0.85 | -0.54 | 0.08 | 0 | -0.46 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.11 | 11.5 | -1.31 | -1.85 | 2.92 | |||||
Gross Profit, 1 Yr. Growth % | 12.7 | 9.18 | 4.3 | 0.83 | 11.52 | |||||
EBITDA, 1 Yr. Growth % | 62.4 | -14.36 | -2.93 | -1.09 | 19.5 | |||||
EBITA, 1 Yr. Growth % | 77.34 | -16.59 | -3.72 | -1.82 | 22.87 | |||||
EBIT, 1 Yr. Growth % | 117.59 | -20.38 | -4.07 | -2.55 | 32.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 141.01 | -33.26 | -22.62 | -8.29 | 39.51 | |||||
Net Income, 1 Yr. Growth % | 158.3 | -34.79 | -35.92 | 23.4 | 20.62 | |||||
Normalized Net Income, 1 Yr. Growth % | 160.41 | -27.65 | -12.59 | -1.64 | 48.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 148.98 | -31.97 | -21.69 | -6.15 | 43.44 | |||||
Accounts Receivable, 1 Yr. Growth % | -8.99 | 19.58 | 1.61 | 6.63 | 9.11 | |||||
Inventory, 1 Yr. Growth % | 6.1 | 31.49 | 1.29 | -21.26 | 4.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.64 | -1.52 | -0.32 | -3.96 | 2.61 | |||||
Total Assets, 1 Yr. Growth % | -0.72 | 0.65 | 0.89 | -5.05 | 4.95 | |||||
Tangible Book Value, 1 Yr. Growth % | 37.42 | 14.68 | -19.91 | -6.26 | 19.38 | |||||
Common Equity, 1 Yr. Growth % | 2.26 | -0.32 | -1.05 | -4.98 | 1.49 | |||||
Cash From Operations, 1 Yr. Growth % | 32.12 | -68.02 | 102.87 | 21.25 | 58.79 | |||||
Capital Expenditures, 1 Yr. Growth % | 20.63 | 5.58 | -1.65 | 0.34 | -1.01 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 29.47 | -81.06 | 92.75 | 128.41 | 5.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 28.8 | -79.7 | 100.15 | 114.69 | 3.98 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.77 | 7.27 | 6.78 | 6.35 | 5.97 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.33 | 10.8 | 4.9 | -1.58 | 0.51 | |||||
Gross Profit, 2 Yr. CAGR % | 7.75 | 10.93 | 6.66 | 2.53 | 6.04 | |||||
EBITDA, 2 Yr. CAGR % | 37.64 | 17.93 | -8.92 | -2.06 | 8.72 | |||||
EBITA, 2 Yr. CAGR % | 48.51 | 21.62 | -10.5 | -2.83 | 9.83 | |||||
EBIT, 2 Yr. CAGR % | 58.64 | 31.62 | -12.75 | -3.38 | 13.84 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 159.77 | 26.83 | -28.13 | -15.76 | 13.11 | |||||
Net Income, 2 Yr. CAGR % | 35.43 | 29.78 | -35.36 | -11.08 | 22 | |||||
Normalized Net Income, 2 Yr. CAGR % | 70.76 | 37.26 | -20.63 | -7.93 | 20.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 151.99 | 30.15 | -27.01 | -14.27 | 16.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | -9.9 | 4.32 | 10.23 | 4.09 | 7.86 | |||||
Inventory, 2 Yr. CAGR % | 1.46 | 18.12 | 15.41 | -10.7 | -9.37 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.13 | -2.09 | -0.92 | -2.16 | -0.73 | |||||
Total Assets, 2 Yr. CAGR % | -0.06 | -0.04 | 0.77 | -2.13 | -0.18 | |||||
Tangible Book Value, 2 Yr. CAGR % | 40.37 | 25.53 | -4.17 | -13.36 | 5.78 | |||||
Common Equity, 2 Yr. CAGR % | 2.19 | 0.96 | -0.69 | -3.04 | -1.8 | |||||
Cash From Operations, 2 Yr. CAGR % | 59.64 | -35 | -19.46 | 56.84 | 38.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | -29.81 | 12.86 | 1.9 | -0.66 | -0.34 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -27.36 | -50.48 | -39.78 | 109.66 | 55.15 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -27.64 | -48.87 | -36.47 | 107.15 | 49.41 | |||||
Dividend Per Share, 2 Yr. CAGR % | 18.75 | 6.52 | 7.03 | 6.56 | 6.16 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.09 | 8.03 | 6.61 | 2.6 | -0.1 | |||||
Gross Profit, 3 Yr. CAGR % | 2.98 | 8.22 | 8.64 | 4.67 | 5.44 | |||||
EBITDA, 3 Yr. CAGR % | 19.19 | 17.5 | 10.44 | -6.41 | 4.66 | |||||
EBITA, 3 Yr. CAGR % | 23.74 | 22.53 | 12.41 | -7.73 | 5.07 | |||||
EBIT, 3 Yr. CAGR % | 24.03 | 26.07 | 18.32 | -9.52 | 7.48 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -35.45 | 65.14 | 7.57 | -22.05 | -0.33 | |||||
Net Income, 3 Yr. CAGR % | -29.71 | 6.15 | 2.58 | -19.81 | -1.56 | |||||
Normalized Net Income, 3 Yr. CAGR % | 39.1 | 28.25 | 17.94 | -15.19 | 8.2 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -35.5 | 62.87 | 9.88 | -20.63 | 1.78 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.44 | -0.98 | 3.41 | 9.02 | 5.74 | |||||
Inventory, 3 Yr. CAGR % | -0.82 | 10.62 | 12.22 | 1.6 | -5.95 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.75 | -2.6 | -1.5 | -1.95 | -0.59 | |||||
Total Assets, 3 Yr. CAGR % | -26.96 | 0.17 | 0.27 | -1.21 | 0.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | -53.61 | 31.22 | 8.07 | -4.87 | -3.59 | |||||
Common Equity, 3 Yr. CAGR % | -30.21 | 1.34 | 0.29 | -2.14 | -1.55 | |||||
Cash From Operations, 3 Yr. CAGR % | 78.07 | -6.59 | -5.01 | -7.69 | 57.49 | |||||
Capital Expenditures, 3 Yr. CAGR % | -27.46 | -19.57 | 7.8 | 1.38 | -0.78 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | -53.59 | -22.28 | -6.14 | 66.7 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | -52.63 | -19.59 | -4.7 | 64.63 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 14.8 | 6.61 | 6.8 | 6.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.2 | 10.32 | 3.81 | 4.08 | 4.12 | |||||
Gross Profit, 5 Yr. CAGR % | 2.64 | 7.99 | 4.44 | 5.89 | 7.58 | |||||
EBITDA, 5 Yr. CAGR % | 26.31 | 32.93 | 7.03 | 9.2 | 9.73 | |||||
EBITA, 5 Yr. CAGR % | 28.48 | 42.71 | 8.7 | 11.62 | 11.35 | |||||
EBIT, 5 Yr. CAGR % | 22.4 | 44.24 | 7.75 | 13.27 | 16.47 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 28.11 | -10.5 | -32.62 | 26.16 | 9.75 | |||||
Net Income, 5 Yr. CAGR % | 28.45 | -17.02 | -32.03 | -1.11 | 9.94 | |||||
Normalized Net Income, 5 Yr. CAGR % | 27.92 | 44.49 | 11.14 | 12.21 | 18.88 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 29.5 | -7.89 | -32.23 | 25.99 | 12.3 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | 2.44 | 1.02 | 5.17 | |||||
Inventory, 5 Yr. CAGR % | - | - | 5.38 | 1.54 | 3.03 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 0.67 | -2.42 | -1.19 | |||||
Total Assets, 5 Yr. CAGR % | - | - | -16.93 | -0.75 | 0.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | -37.99 | 11.15 | 7.15 | |||||
Common Equity, 5 Yr. CAGR % | - | - | -19.63 | -0.43 | -0.55 | |||||
Cash From Operations, 5 Yr. CAGR % | - | 25.96 | 29.65 | 14.92 | 10.54 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | -12.6 | -16.9 | -12.49 | 4.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | -15.28 | 2.44 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | -14.64 | 3 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 11.43 | 6.43 |
- Stock Market
- Equities
- CTVA Stock
- Financials Corteva, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















